End-stage liver disease patients at lower risk for death in the short term still reaped the substantial benefits of a living-donor liver transplant (LDLT), a case-control study revealed. Compared with ...

Since its proposal, the Model for End-Stage Liver Disease (MELD) score has been employed to predict short-term mortality among patients with chronic liver disease and those awaiting liver ...

Replacing serum creatinine with estimated glomerular filtration rate in a patient’s MELD-Na score appeared to improve waitlist mortality prediction among patients with cirrhosis in need of a liver ...